A bacterium from frog gut microbiota eliminated tumors in mice by selectively colonizing tumors and triggering both direct ...
Researchers are exploring an unconventional cancer treatment that uses engineered bacteria to target the unique, oxygen-free ...
Morning Overview on MSN
Zeaxanthin may boost anti-tumor immune response in cancer care
Checkpoint inhibitors have transformed cancer treatment over the past decade, helping hundreds of thousands of patients by ...
SurvivorNet on MSN
'Very promising': New cancer drug, Plixorafenib, shows promise for hard‑to‑treat brain tumors as FDA speeds its development
The U.S. Food and Drug Administration (FDA) has granted plixorafenib a Breakthrough Therapy Designation, signaling ...
A new study co-led by the Institute for Systems Biology (ISB) shows that some lung cancers can change identity as they evolve, shifting from one cancer type to another in ways that may make them more ...
While human and mice tumors share many of the same molecular markers, including many shared genes, there are differences, including our natural immune responses and our immune systems in general.
Solid tumors often contain regions with very low oxygen levels, especially in their inner core. While these hypoxic ...
Portland scientists at Oregon Health & Science University say they have figured out why pancreatic tumors so often brush off ...
A clinical trial for patients with high-grade neuroendocrine tumors is now open for enrollment at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine.
Researchers at The University of Texas MD Anderson Cancer Center have identified an epigenetic target for replication stress, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results